European Congress on

Vaccines & Vaccination

Theme: Drifts in Traditional and innovative Vaccines Approaches

Event Date & Time

Event Location

Hyatt Place, Amsterdam Airport, Netherlands

16 years of lifescience communication

Performers / Professionals From Around The Globe

Tracks & Key Topics

Euro Vaccines 2018

About Conference

Vaccines Committee delighted to welcome all the interested and enthusiastic participants across the globe to its prestigious ‘European Congress on Vaccines & Vaccination’ to be held during August 23-24, 2018 at Amsterdam, Netherlands. which highlights the theme “The Current Challenges in Vaccine Research and Development”. Euro Vaccines 2018 is a two day conference concentrating on Interactive Sessions & Sub-sessions emphasized on innovation and new trends on vaccines, keynote lectures from Senior Scientists and industry experts, panel discussions, poster competitions and Young Researcher Forum. The conference program will feature well-known and thought provoking speakers to interactive discussion sessions, prompt keynote presentations, Oral talks, Poster presentations and Exhibitions  

Why to attend??

The Vaccine & Vaccination conference interacts with members across the globe focused on learning about vaccines and its specialties. This is the single best opportunity to reach the largest participants. Sharing the knowledge and demonstrations, information and B2B meetings with industrialists and potential clients to make a splash with innovative products live and brand recognition at this event. World renowned speakers, the most recent techniques, and the latest updates on vaccines are hallmarks of this conference.

EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi-professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

Euroscicon are corporate members of the following Organizations

  • Royal Society of Biology
  • IBMS
  • British Society for Immunology
  • Rare Care UK
  • Opportunities for Conference Attendees
  • For Researchers & Faculty
  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering

Marketing and Networking with clients

Euroscicon organizes International Vaccine Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands Russia, Bulgaria, France, with solitary subject of quickening logical revelations.


1.  Vaccines Technology:

The disclosure of antibodies has prompted the close annihilation of a few critical maladies and has tremendously affected wellbeing for a moderately ease. Nonetheless, most antibodies being used today were created by procedures that were spearheaded over 100 years prior and don't speak to the maximum capacity of the field. The presentation of hereditary building has powered fast advances in immunization innovation and is currently prompting the passage of new items in the commercial center

  • Attenuated vaccine
  • Inactivated vaccine
  • Toxoid vaccine
  • “Naked” DNA vaccines
  • Edible vaccines
  • Subunit vaccine

2.  Emerging diseases:

Rising irresistible sicknesses speak to a grave risk to creature and human populaces as far as their effect on worldwide wellbeing, farming and the economy. Antibodies created for rising contaminations in creatures can secure creature wellbeing and avert transmission of zoonotic ailments to people. The immunization innovation showcase is relied upon to reach $57,885.4 million by 2019 from $33,140.6 million out of 2014, at a CAGR of 11.8%. Main considerations driving development of antibody innovation advertise incorporate rising commonness of infections, expanding government activities for growing inoculation over the globe, expanding organization interests in immunization improvement, and rising activities by non-government associations for inoculations.

  • Ebola Hemorrhagic Fever (Ebola virus disease)
  • Middle East Respiratory Syndrome (MERS)
  • Chikungunya Virus.
  • H1N1 Influenza Virus (Swine Flu)
  • Avian Influenza (Bird Flu)

3.  Preventable disease vaccines:

An antibody preventable sickness is an irresistible malady for which a compelling preventive immunization exists. On the off chance that a man procures an immunization preventable ailment and passes on from it, the demise is viewed as an antibody preventable passing.

  • Diphtheria
  • Haemophilus influenzae serotype b disease
  • Hepatitis B
  • Meningitis
  • Tuberculosis
  • Yellow fever
  • Mumps
  • Measles

4.  Vaccines for unconventional Disease:

It is fascinating to observe on exercises of medication designers in zone of immunizer prompting immunizations coordinated against non-irresistible sicknesses and some whimsical signs. These immunizations have been much of the time grown so far as treatment antibodies. This is in inverse to irresistible maladies antibodies utilized as prophylactic immunizations. In spite of promising late stage competitors, with some exceptionally late disappointments, there is still no immunizer initiating immunization endorsed focusing on other than microorganism antigens (I. e focusing on self-antigens , dependence particles antigens and others. It is intriguing to observe on exercises of medication engineers in zone of counter acting agent initiating immunizations coordinated against non-irresistible ailments and some unpredictable infections.

  • Vaccines against cancer
  • Vaccines against allergy
  • Vaccines against chronic degenerative diseases
  • Vaccines against autoimmune diseases
  • Vaccines against drug addiction

5.  Vaccines for infectious diseases:

The expansion in future amid the twentieth century is to a great extent because of enhancements in kid survival; this expansion is related with diminishments in irresistible sickness mortality, due to a great extent to immunization. However, irresistible infections remain a noteworthy reason for ailment, incapacity, and demise. Vaccination proposals in the United States right now target 17 antibody preventable illnesses over the life expectancy.

  • Immunity to Infection
  • Immunity to Bacteria & fungi
  • Immunity to viruses
  • Microbial Immunology

6.  Vaccines for non-Infectious diseases:

Misinterpretations and deception posture obstructions to immunizations. For example a report connecting the measles antibody to extreme introvertedness, the paper was later withdrawn however it was utilized by poorly educated associates and hostile to immunization gatherings. Research is seriously expected to create procedures to convey the significance of immunizations to unverifiable guardians.

  • Alzheimer’s disease
  • Diabetes mellitus type
  • Cancer
  • Hepatitis B vaccine
  • Atherosclerosis vaccine

7.  Developing Technology:

Antibody Research and Development – The field bargains all in all with different sorts of immunizations, their blend, restorative impacts and clinical advancements. The field completely covers every one of the progressions, advancements of antibodies in each field of immunization. Antibodies treating jungle fever, malignancy and numerous different sicknesses can be all things considered concentrated under this field.

  • Effectiveness
  • Nomenclature
  • Developing immunity
  • Dose reduction
  • Paired with multiple antigens
  • Enhance safety

8.  Developing Next Generation Conjugate Medicine:

Antibody–drug conjugates (ADCs) are one of the fastest growing classes of oncology therapeutics. After half a century of research, the approvals of brentuximab vedotin (in 2011) and trastuzumab emtansine (in 2013) have paved the way for ongoing clinical trials that are evaluating more than 60 further ADC candidates. The limited success of first-generation ADCs (developed in the early 2000s) informed strategies to bring second-generation ADCs to the market, which have higher levels of cytotoxic drug conjugation, lower levels of naked antibodies and more-stable linkers between the drug and the antibody.

  • Antibody-drug conjugate
  • Targeted Delivery Through Conjugation
  • Comprehensive ADC Solutions
  • Auristatin based ADCs
  • Maytansinoid based ADCs

9.  Carbohydrate based vaccines:

Starches are viewed as promising focuses for immunization improvement against irresistible ailment since cell surface glycans on numerous irresistible operators are credited to assuming a critical part in pathogenesis. Moreover, oncogenic change of ordinary cells, as a rule, is related with deviant glycosylation of the cell surface glycan creating tumor related sugar antigens (TACAs). Mechanical advances in glycobiology have added another measurement to immunotherapy while considering starches as key focuses in creating protected and powerful immunizations to battle disease, bacterial contaminations, viral diseases, and so on. Many consider compelling antibodies prompt T-cell subordinate invulnerability with acceptable levels of immunological memory that block repeat. Shockingly, sugars alone are inadequately immunogenic as they don't tie firmly to the MHC II complex and consequently neglect to evoke T-cell resistance.

  • Abnormal carbohydrates expressed by tumors
  • Choosing and designing proper adjuvants for specific targets
  • Using adjuvants to improve immunogenicity and/or immunological properties of vaccines

10.  Vaccines R&D:

All immunization applicants must be put through a protracted, thorough procedure of logical assessment before they can be authorized for general utilize. This procedure is tedious – it can take up to 10 years just to move a hopeful immunization through the three periods of clinical advancement alone. Be that as it may, it is additionally imperative. The clinical trials in which antibodies are assessed guarantee that authorized immunizations are sheltered, powerful, and fitting for the populaces destined to utilize them. IAVI analysts have extensive involvement in connected research for antibody outline, the interpretation of immunization ideas into testable items, and the assessment of such immunization competitors in beginning period clinical trials.

  • Basic Research
  • Discovery 
  • Preclinical Evaluation
  • Manufacturing and Regulatory Review
  • Clinical Evaluation

11.  Animal models and research trials:

The development of human vaccines continues to depend on the use of animals for research. Regulatory authorities require novel vaccine prospects to undergo preclinical evaluation in animal models before being permitted to enter the clinical phase in human subjects. Major progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine prospects. Though, the ultimate goal of a new vaccine is to command the immune system to obtain an effective immune response against the pathogen of interest, Animal models in vaccine development.

  • Diagnostic and clinical applications
  • Engineered mouse models in cancer
  • Research and development of viral vaccines, including field trials
  • Alteration and clinical trials in vaccination

12.  Vaccines against drugs:

Globally, drug addiction is a severe problem. One therapy being considered is vaccines against drugs of abuse. The antibodies obtained against the drug can take up the drug and avert it from reaching the reward center in the brain. Few such vaccines have entered clinical trials, but research is going on rapidly.

  • Nicotine vaccines
  • Morphine and heroin vaccines
  • Drug molecules and immune system
  • Linkage chemistry, adjuvants and immunological proteins
  • Cocaine vaccines

13.  Biodefense  vaccines against bioterrorism:

In spite of the defensive adequacy of antibodies against singular living beings, the high expenses and the considerable troubles associated with inoculating extensive populaces, alongside the expansive range of potential operators, make it difficult to utilize immunizations to secure the all-inclusive community against bioterrorism.

  • Anthrax and  smallpox
  • Plague and tularemia
  • Ebola, Marburg, Lassa, and machupo virus
  • Q fever, ricin toxin, typhus fever
  • Nipah virus

14.  Vaccines for pregnant women and neonates:

Immunizations can help keep you and your developing family solid. On the off chance that you are pregnant or arranging a pregnancy, the particular immunizations you require are controlled by elements, for example, your age, way of life, restorative conditions you may have, for example, asthma or diabetes, sort and areas of travel, and past inoculations. The Advisory Committee on Immunization Practices (ACIP) suggests that all youngsters get their first dosage of Hepatitis B antibody during childbirth and finish the antibody arrangement by age 6– year and a half.

  • Immunization during or before pregnancy / delivery
  • HIV and other STD vaccines for pregnant women
  • Influenza vaccination of pregnant women and protection of their infants
  • HPB, HAV, HBV vaccination for neonates
  • Whooping cough vaccines in pregnant women
  • Halting vaccination in pregnancy
  • Chiropractic vaccination care in women and pregnancy

15.  Vaccine Delivery Systems and Adjuvants:

Routinely the proficiency of an adjuvant is measured by the ability to instigate upgraded Vaccine serum titers and cell interceded invulnerability (CMI) to a given antigen. In the early period of inoculation a few adjuvants impact the antigen organization and take-up by a purported terminal impact exemplified by aluminum hydroxide gel and oil adjuvants, which conceivably isn't as wanted as alleged

  • Inulin-derived adjuvant
  • Cytokines as adjuvants
  • Bacteria-derived adjuvants
  • Tensioactive adjuvants
  • Organic & inorganic adjuvants
  • Aluminum in vaccines
  • Latest techniques and advancements in vaccines delivery systems

16.  Novel Vaccines - Production & Development:

Roughly 250 researchers and immunization specialists from around the globe assembled at Cambridge Healthtech Institute's third Annual Immunotherapeutic and Vaccine Summit (ImVacS 2008) to show the most recent advancements in this field and to talk about, in 64 introductions, the difficulties and flow ways to deal with improvement and generation of novel antibodies.

  • Production using plant, insect cells or bacteria cultures
  • Clinical development of vaccines
  • Investigational vaccines manufacture
  • Mammalian cells-based vaccines
  • Egg-based vaccines

17.  Plant based vaccines:

The vaccines in which the desired genes that encode the antigen protein for specific disease are introduced into the genome of plant tissue by various methods are termed as plant-based vaccines. The most common procedures that are used to yield effective plant- based vaccines are Agrobacterium-mediated gene transfer and Transformation via genetically modified plant virus. Though, growth in the field of science and technology established new approaches such as agro infiltration, biolistic, electroporation, polyethylene glycol treatment and sonication to replace the former methods.

  • To increase the efficacy of gene delivery
  • Plastid Methods transformation
  • Immunogen design and gene synthesis
  • Plant based vaccines production
  • Challenges of plant based vaccines

18.  Biotechnology and modern vaccine technology:

Biotechnology is used in the evolution of vaccine in three different processes: Using a special monoclonal antibody in the segregation of pure antigens, using cloned genes for the synthesis of antigens, synthesized proteins used as vaccines. Recombinant vaccines are vaccines yielded from recombinant DNA Technology. They are also termed as subunit vaccines.

  • Recombinant vaccines
  • Hydrophobic Nanoparticle Technology
  • TLR Agonists
  • Surfaced Arrayed Therapeutics
  • Immunopurification
  • Synthetic peptides
  • Modern vaccine formulation technologies



Market Report

Euro Vaccine 2018 welcomes attendees, presenters, and exhibitors from all over the world to Amsterdam, Netherlands. We are delighted to invite you all to attend and register for the “European Congress on Vaccines & Vaccination” which is going to be held during August 23-24, 2018 at Amsterdam, Netherlands

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Euro Vaccine 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Vaccines organizing committee look forward to meeting you in Amsterdam.

Importance & Scope:

Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) and Type - Forecast to 2022", The antibodies showcase is relied upon to achieve USD 49.27 Billion by 2022 from USD 34.30 Billion of every 2017, at a CAGR of 7.5%. The development of the market is ascribed to the rising predominance of illnesses, expanding government and nongovernment subsidizing for antibody improvement, and expanding ventures by organizations.

In view of innovation, the Vaccines showcase is divided into conjugate antibodies, inactivated and subunit Vaccines, live lessened antibodies, recombinant antibodies, and toxoid antibodies. In 2017, the conjugate section is relied upon to represent the biggest offer of the antibodies advertise. The development in this market is for the most part determined by expanding speculations by the legislature of creating countries and rising pervasiveness of irresistible maladies.

In 2017, North America is required to rule the market. The huge offer of this topographical portion is ascribed to elements, for example, expanding ventures by government associations and organizations to advance inoculation and additionally grow new Vaccines. In 2017, Europe is relied upon to hold the second biggest offer of this market. Factors, for example, accessibility of subsidizing and funding ventures for the advancement of new antibodies and expanding government activities are required to drive advertise development in this locale.

The investigation appraises the antibodies advertise estimate for 2017 and ventures its request till 2022. In the essential research process, different sources from both request side and supply side were met to acquire subjective and quantitative data for the report. Essential sources from the request side incorporate different industry CEOs, VPs, showcasing chiefs, innovation and development executives, and related key officials from the different players in the Vaccine advertise. For the market estimation process, both best down and base up approaches were utilized to gauge and approve the market size of the worldwide market and in addition to assess the market size of different other ward submarkets. Every single conceivable parameter that influence the market shrouded in this examination contemplate have been represented, seen in broad detail, confirmed through essential research, and broke down to get the last quantitative and subjective information. This information was combined and added to itemized sources of info and investigation.

Euro Vaccine 2018 is an international platform for presenting research about Novel Vaccines - Research and Development, Cancer Vaccines, Vaccines Formulation & Discovery, DNA Vaccines, Novel Vaccines - Development and Production, Vaccine Delivery Systems and Adjuvants, Hepatitis, HIV and STD Vaccines, Vaccination for Emerging and Re-emerging Diseases, Biodefense Vaccine against Bioterrorism, Vaccines for Immune Mediated Diseases, Vaccines for Pregnant Women and Neonates, Antibodies : Engineering and Therapeutics, Animal Models and Clinical Trials, Future Challenges & Current Research and Others for the benefit of both the academia and business. This event brings together world class scientists, Researchers and Academicians to explore the recent advancements that are taking place in the field of Vaccines & Vaccination.


Why Amsterdam?

Rated one of Europe's top destinations, a visit to Amsterdam means a schedule packed full of museums, attractions, nightlife and more. Here you will find plenty of information to offer your clients a unique and memorable visit to Amsterdam.

An iconic city that offers your guests plenty to see and do, The Amsterdam Metropolitan Area is home to some of the world’s biggest museums, most iconic locations and, of course, the 400-year-old Canal Ring. Amsterdam is also a top international destination for conventions and conferences, and hosts an average of 650 meetings per year, which draw over 700,000 business visitors.

Visitors of all types will have plenty to do while they’re here. The city’s cultural agenda is packed with world-class exhibitions, theatre performances, live music and other unique events, and its charming neighbourhoods are full of unique shops, cafes and restaurants. The resources below will help you navigate these, and plan the right itinerary for your guests.

Most parents in the Netherlands (over 95%) have their children vaccinated. The first round is performed between the ages of 0 and 4. When they reach the age of 9, two vaccinations are repeated: DTP (diphtheria, tetanus and polio) and MMR (measles, mumps and rubella; in Dutch BMR). Girls are also offered vaccination to protect them against cervical cancer in the year they turn 13. These vaccinations are free of charge.

Conference Highlights:

  • Novel Vaccines - Research and Development
  • Cancer Vaccines
  • Vaccines Formulation & Discovery
  • DNA Vaccines
  • Novel Vaccines - Development and Production
  • Vaccine Delivery Systems and Adjuvants
  • Hepatitis, HIV and STD Vaccines
  • Vaccination for Emerging and Re-emerging Diseases
  • Biodefense Vaccine against Bioterrorism
  • Vaccines for Immune Mediated Diseases
  • Vaccines for Pregnant Women and Neonates
  • Antibodies: Engineering and Therapeutics
  • Animal Models and Clinical Trials
  • Future Challenges & Current Research

Top Immunology and Vaccine Research Universities Worldwide

Immunology and Vaccine Universities in Europe

Ludwig Maximilians University Munich, Germany | Charité-Universitätsmedizin Berlin, Germany | Wroclaw Medical University, Wroclaw, Poland | Finnish Institute of Occupational Health, Helsinki, Finland | Technical University Munich, Germany | University of Pisa, Italy | University of Messina, Messina, Italy University Laboratory of Medical Research-University of Verona, Italy | Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark | Wageningen University, the Netherlands | University Medical Centre Utrecht, The Netherlands | National Institute of Allergy and Infectious Disease | University of Bologna, Bologna, Italy  | Clermont-Ferrand, France | Imperial College London, London | Manchester Institute of Biotechnology | University Hospitals of Geneva and University of Geneva, Geneva, Switzerland | Centre for HIV Research | Zealand University Hospital, Denmark | Odense University Hospital, Denmark | Aarhus University, Denmark | Tampere University Hospital, Tampere, Finland | University of Tampere School of Medicine and Fimlab Laboratories, Tampere, Finland | Helsinki University Central Hospital, Helsinki, Finland | University of Foggia, Italy | National Research Council (CNR), Avellino, Italy | University of TampereOslo University Hospital, Norway | Norwegian Institute of Public Health, Oslo, Norwa | University of Bonn, Bonn, Germany | University of Warmia and Mazury, Olsztyn, Poland Montana State University, Bozeman, Montana | Medical University of Vienna, Vienna, Austria Second University of Naples, Naples, Italy | University of Copenhagen, Hellerup, Denmark |  Necker Children's Hospital, Paris, France | Paracelsus Private Medical University Salzburg, Austria Medical University of Innsbruck, Austria | Krankenanstalt Rudolfstiftung, Wien, Austria | Bispebjerg University Hospital, Copenhagen, Denmark | University of Lille, France | 

Immunology and Vaccine Universities in USA

University of British Columbia, Vancouver, Canada | McGill University Faculty of Medicine,Montreal, Canada | University of Manitoba, Winnipeg, MB, Canada | University of Saskatchewan, Saskatoon, SK, Canada | Vaccine Researcg Center Labs | University of Veracruz, Veracruz, México | Stanford University, Stanford, USA | Universidad Autonoma de Sinaloa, Mexico | University of California, Davis, USA | Federal University of Bahia, Salvador, Bahia, Brazil | Universidad Autónoma, Mexico | University of Sao Paulo School, Brazil | University Estadual Paulista, Brazil | College of Medicine Miguel Aleman Valdes, Veracruz, Veracruz, Mexico | Vaccine and Infectious Disease DivisionUniversity of Brasília, Brasília, Brazil | Institute of Biomedical Research, Brazil | Centre for Vaccine Awareness and ResearchDepartment of Internal Los Alamos National Laboratory, Los Alamos, New Mexico, USA |McMaster University, Hamilton, Ontario, Canada | Health Sciences Centre, Winnipeg, MB, Canada | Western University, London | McGill University and Research Institute, Canada | Royal University Hospital, CanadaMedicine, University of New Mexico, USA | Vaccine Research Unit | Dalhousie University, Halifax, Nova Scotia, Canada | University of Alberta, Edmonton, Canada | University of Toronto, Toronto, Canada | Memorial University of Newfoundland, Canada | University Avenue, Toronto, Ontario, Canada | University of New Mexico Cancer Center, Maxico  | Universidad Autónoma de Nuevo León, Monterrey, Mexico | Duke Human Vaccine InstituteZealand's University Hospital, Koge, Denmark | Hospital Infantil de México Federico Gómez, México | Biomedicine In the Post-Genomic Era, Mexico | Nuevo Hospital Civil de Guadalajara, Mexico | Centro de Ciencias de la Atmósfera, Mexico | Université de Montréal, Montreal, Quebec, Canada | 

Immunology and Vaccine Universities in Asia

The University of Western Australia, Perth, Australia | The Chinese University of Hong Kong | Prince of Wales Hospital, Hong Kong, China | Singapore Clinical Research InstituteThe Hong Kong Polytechnic University, Hong Kong, China |  Nanchang University, Nanchang, China |  The University of Hong Kong, Hong Kong, China | 7 Baptist University Road, Kowloon Tong, Hong Kong, China | Gadjah Mada University, Yogyakarta, Indonesia | International Vaccine InstituteTrivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India | University of Putra Malaysia | Andalas University-M. Djamil Hospital, Padang, Indonesia | Bina Nusantara University, Jakarta, Indonesia | University of Indonesia, Jakarta, Indonesia |  Seirei Hamamatsu Hamamatsu, Shizuoka, Japan | Wakayama Medical University, Kimiidera, Japan | UCSI University, Malaysia | Institute for Medical Research, Kuala Lumpur, Malaysia | Asia Research InstituteUniversity of Otago, Christchurch, Christchurch, New Zealand | Murdoch Childrens Research Institute, Melbourne, Australia | University of Sydney, Sydney, New South Wales, Australia | The University of Melbourne | University of Newcastle, Tamworth, Australia | The University of Auckland, New Zealand | The Medical City Hospital, Pasig City, Philippines | National University of Singapore, Singapore | Kyungpook National University, Daegu, South Korea | United Arab Emirates University, UAE | National Taiwan University Hospital, Taipei, Taiwan | International Livestock Research Institute | Zhejiang University School of Medicine, Hangzhou, China Hong Kong Polytechnic University, Hong Kong, China | Yamaguchi University Graduate School of Medicine, Ube, Japan | Central Health Medical Practice, Hong Kong, China |

Top Immunology Societies and Associations Worldwide

Council on Foreign Regulations | NCD Alliance | Global Health Council |Non Communicable Diseases | General Assembly of the United Nations | Pan American Group for Immunodeficiency | Society for Immunotherapy of Cancer Dutch Society of Allergology | Norwegian Society of Allergology and Immunopathology | Polish Society of Allergology | International Society of VaccinesInternational Federation of Red Cross and Red Crescent Societies( IFRC) | International Society for Disease Surveillance | World Health Federation | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology | British Society for Immunology  | International Society for Vaccines  | International Society of Neuroimmunology  | The Japanese Society for Neuroimmunology | Latvian Society of Neuroimmuologists | Non Communicable Diseases- World Medical Association | World Health Organization| Non Communicable Diseases | Immunization Action Coalition | Global Health and Non communicable Diseases  |  European Federation of Immunological Societies: EFIS | European Academy of allergy and clinical immunology Immunological Association in UK | The American Association of Immunologists (AAI)|  American Academy of Allergy, Asthma & Immunology | Federation of Clinical Immunology Societies (FOCIS) | American Association of Veterinary Immunologists (AAVI) | Nature Immunology Association American Society for Reproductive Immunology | Allergy/Immunology American Medical Association | American Association of Immunologists Association of Medical Laboratory Immunologists | Immunology of Diabetes Society | International Cytokine Society International Society for Neuroimmunology | International Society of Developmental and Comparative Immunology | International Union of Immunological Societies | Pan American Group for Immunodeficiencies| Society for Mucosal Immunology | European academy of Tumor Immunology |  Cyprus Society for Allergology and Immunology | Czech Society of Allergology and Clinical Immunology | Danish Society of Allergology | Estonian Society for Immunology and Allergology | Finnish Society of Allergology and Immunology |  Hungarian Society of Allergology and Clinical Immunology | Icelandic Society of Allergology and Clinical Immunology | Irish Association of Allergy and Immunology | Italian Society of Allergology and Clinical Immunology | Latvian Association of Allergist | Lithuanian Society of Allergology and Clinical Immunology | SocieteLuxembourgeoised’Allergologie et d’Immunologie F.Y.R.O.M. Society of Allergy and Clinical Immunology |American Society for Histocompatibility and Immunogenetics | Asia Pacific Associationof Pediatric Allergy, Respirology& Immunology (APAPARI) | Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) | International Union of Immunological Societies | Pediatric Allergy and Immunology and Association | Allergy & Immunology Society of Sri Lanka | Allergy and ClinicalImmunology Society (Singapore) | American Academy of Allergy, Asthma and Immunology | British Society for Immunology | Commonwealth of Independent States Society of Allergology and Clinical Immunology | Clinical Immunology Society |  Portuguese Society of Allergology and Clinical Immunology | Romanian Society of Allergology and Clinical Immunology | Russian Association of Allergology and Clinical Immunology | Association for Allergology and Clinical Immunology of Serbia| Slovakian Society of Allergology and Clinical Immunology | Slovene Association of Allergology and Immunology | Spanish Society of Allergology and Clinical Immunology | Swedish Association for Allergology | Swiss Society of Allergology and Immunology | Turkish Society of Allergy and Clinical Immunology | Ukrainian Society of Allergy and Clinical Immunology | Georgian Association of Allergology and Clinical Immunology German Society for Allergology and Clinical Immunology | Hellenic Society of Allergology and Clinical Immunology | Australasian Society for Immunology | Federation of Immunological Societies of Asia-Oceania |  Belgian Society for Allergy and Clinical Immunology | British Society for Allergy and Clinical Immunology | Clinical Centre of Allergology | Croatian Society for Allergology and Clinical Immunology |

Top Immunology and Vaccine Journals Worldwide

Journal of Allergy and Clinical Immunology | Journal of Clinical Immunology | Molecular Immunology | Human Vccines & Immunotherapeutics | Microbiology | Vaccine | European Journal of Immunology | Nature | Pediatric Allergy and Immunology | Clinical and Experimental Immunology | Clinical and Vaccine Immunology | Elsevier Journal of VaccineNature Reviews Immunology | Immunology and Cell Biology | Nature Immunology | International Immunology | International Journal of Vaccines and ImmunizationAnnals of Allergy, Asthma & Immunology | Immuno biology | Cell | Human Immunology | Veterinary Immunology and ImmunopathologyInfection and Immunity | Allergy | Immuno pharmacology | American Journal of Reproductive Immunology | Journal of Neuroimmunology | World journal of VaccineCancer Immunology, Immunotherapy | Journal of Asthma | Brain, Behavior, and Immunity | Critical Reviews in Immunology | Clinical Reviews in Allergy & Immunology | Cytokine | Immunity| Medical Microbiology and Immunology | NPJ Vaccines JournalInternational Reviews of Immunology | Immuno genetics | Clinical & Experimental Allergy | Immunotherapy journal | Inflammation Research | Autoimmunity | Journal of Leukocyte Biology | Journal of Leukocyte Biology Wiley | Journal of Investigational Allergology and Clinical Immunology | Clinical and Experimental Vaccine ResearchInternational journal of immunotherapy | journal of immunotherapy of cancer | Veterinary immunology journal | European journal of allergy and clinical immunology | American Journal of Immunology | Journal of Clinical Immunology | Journal of Immunology Research | American Journal of clinical and experimental Immunology | Journal of clinical Immunology |  Asian Pacific Journal of Allergy and Immunology NCBI | European Journal of Experimental Biology | Journal of Vaccines & Vaccination | Rheumatology: Current ResearchJournal of Blood & Lymph | Immunome Research | Journal of Immunological Techniques & Infectious Diseases | Immunogenetics: Open Access | Journal of Autoimmune Disorders | Journal of Vasculitis | Immunochemistry & Immunopathology | International Journal of Inflammation, Cancer and Integrative Therapy | Journal of Cancer Research and Immuno-Oncology | Journal of Clinical and Experimental Transplantation | Journal of Transmitted Diseases and ImmunityImmunological Disorders & Immunotherapy | Archives of Inflammation | Journal of Vaccines & Clinical Trials

Immunology and Vaccine Job Opportunities

Scientific Research in Immunology | Physicians and Pediatricians in Immunology | College Teaching and Research of Immunology | In Vivo Research Scientist in VaccineAssociate Professor of  Immunology | Assistant Professor of  Immunology | 2018 MRL Immunology Intern Auto-Antigens in Autoimmune Diseases | Cancer Immunologist & System biologist | Directors of Research Divisions and SWIMSPost-doctoral positions in Immunotherapy | Associate Scientist in ImmunochemistryResearch Faculty in Immunology | Postdoctoral Researcher in Tumor Immunology | Postdoctoral Fellow - Diabetes, Obesity & Metabolism Institute | Senior Translational Scientist in Immunology | Postdoctoral Fellow  in Immunology | Associate Editorial in Immunology |  Project Manager in Immunology | Principal Investigator | Post Doctoral Position in Huntington's Disease Research in ImmunologyBiomedical Sciences Faculty Positions - Cluster Hire in Immunology | Assistant Professor of Immunology at MIT-Ragon Institute | Computational Biology Faculty Position in Immunology | Principal Investigator - Infectious Disease Research | Associate Program Officer, Crohn's Disease in Immunology | Assistant or Associate Professor - Immunologist/Immunopathologist  | Faculty Position in Biomedical Engineering at UC Davis in Immunology | Research Scientist Position: Cellular Immunotherapy (GMP) R&D Lead | Chif Scientific Officer and Vice President, Science and Education in Immunology | Senior Scientific Writer in Immunology Pathology FTE Immunogenetics in Immunology  | Immune Assessment in Immunology | Assistant Professor of Human Disease Models in Immunology | Post-doctoral Position in Mucosal Immunology/Inflammatory Bowel Disease | Senior Faculty Positions in the Life Sciences Translational Research in Gastrointestinal & Hepatobiliary Cancers | Cancer Experimental Therapeutics | Research Associate Technician-Therapeutic Tumor  | Assistant Professor, Marine Disease Biology | Principal Investigator of Immunology | Post Doc in Immunology & Respiratory Diseases Research in Immunology  | Post-Doctoral Scientist position in Immunology Tenure Track Assistant Professor in Immunology | Postdoctoral Research Fellow in Immunology | Faculty Position in Immunology

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!